170621-85-9

Basic information

• Product Name: (4-chloro-3-Methoxypyridin-2-yl)Methanol
• Synonyms: (4-chloro-3-Methoxypyridin-2-yl)Methanol
• CAS NO: 170621-85-9
• Molecular Formula: C7H8ClNO2
• Molecular Weight: 173.59692
• EINECS: -0
• Mol File: 170621-85-9.mol
• Article Data: 5

Chemical Properties

• Appearance: /
• CAS DataBase Reference: (4-chloro-3-Methoxypyridin-2-yl)Methanol(CAS DataBase Reference)
• NIST Chemistry Reference: (4-chloro-3-Methoxypyridin-2-yl)Methanol(170621-85-9)
• EPA Substance Registry System: (4-chloro-3-Methoxypyridin-2-yl)Methanol(170621-85-9)

Safety Data

• Hazardous Substances Data: 170621-85-9(Hazardous Substances Data)

Usage

General Description

(4-chloro-3-Methoxypyridin-2-yl)Methanol is a chemical compound with potential medicinal and pharmaceutical applications. It is a derivative of pyridine, a heterocyclic organic compound, and contains a chloro and methoxy functional group. The presence of these functional groups makes it a versatile building block for the synthesis of various pharmaceutical compounds and potential drug candidates. The chemical structure of (4-chloro-3-Methoxypyridin-2-yl)Methanol suggests that it may have biological activity, making it a promising target for medicinal chemistry research. Its properties and potential applications make it a valuable compound in the field of drug discovery and development.

Upstream product

• 122307-41-9 4-chloro-3-methoxy-2-methylpyridine N-oxide 

Downstream Products

• 335428-53-0 4-chloro-3-methoxypyridine-2-carbaldehyde 
• 503058-51-3 4-chloro-2-chloromethyl-3-methoxypyridine hydrochloride 

Relevant articles and documents

ISOTOPICALLY SUBSTITUTED PROTON PUMP INHIBITORS

The invention relates to benzimidazoles of Formula (1) and to pharmaceutical compositions comprising these compounds, further to intermediates of Formula (2 and 3).

EP4 RECEPTOR AGONIST, COMPOSITIONS AND METHODS THEREOF

This invention relates to potent selective agonists of the EP4 subtype of prostaglandin E2 receptors, their use or a formulation thereof in the treatment of glaucoma and other conditions, which are related to elevated intraocular pressure in the eye of a patient. This invention further relates to the use of the compounds of this invention for mediating the bone modeling and remodeling processes of the osteoblasts and osteoclasts.

SUBSTITUTED HETEROCYCLIC CARBOXAMIDE ESTERS, THEIR PREPARATION AND THEIR USE AS PHARMACEUTICALS

The invention relates to compounds of the formula I, to a process for their preparation and to their use as pharmaceuticals. The compounds are employed, in particular, as ester prodrugs of prolyl hydroxylase inhibitors for inhibiting collagen biosynthesis and as fibrosuppressive agents